Associate Clinical Trial Manager - Radiopharmaceuticals

Medpace is currently seeking candidates with PhDs and/or Post-Doctoral Research experience in nuclear medicine, medical physics, medical imaging / radiopharmaceuticals or / radiation oncology for a full-time, office-based Associate Clinical Trial Manager (aCTM) to join our Clinical Trial Management team. The aCTM will work with Project Coordinators and Clinical Trial Managers in performance of clinical trial management activities. Candidate must have a desire to transfer and apply analytical and academic skills in clinical project administration and management.

A fantastic opportunity for recent PhD graduates to enter the industry, receive solid foundational training, work in an international environment, and develop their career in the research and development of cutting-edge radiopharmaceuticals (molecular radiotherapy, radiotheranostics, targeted radionuclide therapy). Candidates should expect to have an intensive training period and show the desire and aptitude for an accelerated career path into Clinical Trial Management (CTM).

• Communicate and collaborate on global study activities; working closely with the Project Coordinator and Clinical Trial Manager
• Ensure timely delivery of recurrent tasks consistently with a high degree of accuracy
• Compile and maintain project-specific status reports within the clinical trial management system
• Interact with the internal project team, Sponsor, study sites, and third-party vendors
• Provide oversight and quality control of our internal regulatory filing system
• Provide oversight and management of study supplies
• Create and maintain project timelines
• Coordinate project meetings and produce quality minutes

• PhD or Post-Doc related to Radiopharmaceuticals (nuclear medicine/medical physics/medical imaging/radiation oncology or related)
• Fluency in English with solid presentation skills
• Ability to work in a fast-paced dynamic industry within an international team
• Prior experience within the CRO or pharmaceutical industry not required but will be advantageous